不适合移植的大 B 细胞淋巴瘤二线使用 axicabtagene ciloleucel:ALYCANTE 最终分析
Second-line axicabtagene ciloleucel in large B-cell lymphoma ineligible for transplantation: ALYCANTE final analysis.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:A novel prognostic model based on CA stage for enhanced stratification and survival prediction in patients with Natural killer/T-cell lymphoma.
A novel prognostic model based on CA stage for enhanced stratification and survival prediction in patients with Natural killer/T-cell lymphoma.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
本研究旨在确定基于L-天冬酰胺酶/培门冬酶治疗的Natural killer/T-cell lymphoma(NKTCL)关键预后因素,并开发一个简化而准确的风险分层预后模型。来自中山大学肿瘤防治中心的854例NKTCL患者数据被分为训练队列(n = 598)和内部验证队列(n = 256)。
另外来自四川省肿瘤医院·研究所的222例患者被用于建立外部验证队列。采用最小绝对收缩和选择算子(LASSO)和Cox回归确定总生存期(OS)的独立危险因素。构建了列线图(Nomogram-CA),并使用一致性指数(C-index)、校准曲线、时间依赖性ROC(tdROC)和决策曲线分析(DCA)进行评估。生成Kaplan-Meier生存曲线以显示各组之间OS的差异。年龄、CA分期、B症状和血红蛋白(Hb)水平均被确定为OS的独立危险因素。根据多因素分析结果构建了Nomogram-CA。DCA曲线表明,Nomogram-CA在训练队列、内部验证队列和外部验证队列中为患者提供了更多净获益。
此外,Kaplan-Meier生存曲线分析显示,与被Nomogram-CA归类为低风险的患者相比,被归类为高风险的患者生存率显著更低(P < 0.05)。基于独立预后因素构建的Nomogram-CA与传统分期系统相比具有更好的预测能力,可帮助临床医生评估患者预后。
This study aimed to identify key prognostic factors for Natural killer/T-cell lymphoma (NKTCL) in the context of L-asparaginase/pegaspargase-based therapy and to develop a simplified yet accurate prognostic model for risk stratification. Data from 854 NKTCL patients at the Sun Yat-sen University Cancer Center were divided into a training cohort (n = 598) and an internal validation cohort (n = 256). A further 222 patients from Sichuan Cancer Hospital & Institute were used to create an external validation cohort. Least absolute shrinkage and selection operator (LASSO) and Cox regression were used to identify independent risk factors for overall survival (OS).
A nomogram (Nomogram-CA) was constructed and evaluated using the consistency index (C-index), calibration curves, time-dependent ROC (tdROC) and decision curve analysis (DCA). Kaplan-Meier survival curves were generated to show the difference in OS between groups.
Age, CA stage, B symptoms and hemoglobin (Hb) level were all identified as independent risk factors for OS. Nomogram-CA was constructed based on multivariate analysis results. The DCA curves demonstrated that Nomogram-CA provided more net benefit to patients in the training, internal validation and external validation cohorts.
Furthermore, analysis of the Kaplan-Meier survival curve revealed a significantly lower survival rate among patients identified as high-risk by Nomogram-CA when compared to those classified as low-risk (P < 0. 05). Nomogram-CA constructed based on independent prognostic factors has better predictive ability compared to the traditional staging system, which can assist clinical doctors in evaluating patient prognosis.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。